Eli Lilly (NYSE: LLY) CEO exercises 31,932 RSUs, reports share disposal
Rhea-AI Filing Summary
Eli Lilly President, Chair, and CEO David A. Ricks reported equity award activity involving company stock on February 1, 2026. He exercised 31,932 restricted stock units, receiving the same number of Eli Lilly common shares at an exercise price of $0 per share.
On the same date, he disposed of 14,296.654 common shares at $1,037.15 per share, leaving 532,801.513 common shares held directly after the reported transactions. Additional indirect holdings are reported through several trusts, GRATs, a SLAT, and a 401(k) plan, with beneficial ownership disclaimed except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 17,635.346 shares
Net Buy
8 txns
Insider
Ricks David A
Role
President, Chair, and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 31,932 | $0.00 | $0.00 |
| Exercise | Common Stock | 31,932 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 14,296.654 | $1,037.15 | $14.83M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 532,801.513 shares (Direct);
Common Stock — 6,685 shares (Indirect, By David A. Ricks 2025 GRAT);
Common Stock — 54,117 shares (Indirect, By David A. Ricks 2022 GRAT);
Common Stock — 300 shares (Indirect, By Trust);
Common Stock — 68,656 shares (Indirect, By David A. Ricks SLAT);
Common Stock — 7,311.26 shares (Indirect, 401(k))
Footnotes (2)
- F1. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F2. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
FAQ
What insider transaction did Eli Lilly (LLY) CEO David A. Ricks report?
David A. Ricks reported exercising 31,932 restricted stock units into Eli Lilly common stock on February 1, 2026. He also reported a related disposition of 14,296.654 common shares, with 532,801.513 common shares held directly after the transactions, plus additional indirect holdings through various trusts and a 401(k).
How many Eli Lilly (LLY) RSUs did David A. Ricks convert to common stock?
He converted 31,932 restricted stock units into 31,932 shares of Eli Lilly common stock at an exercise price of $0 per share. Each restricted stock unit represented a contingent right to receive one share of common stock, according to the filing’s explanatory footnote.
What indirect Eli Lilly (LLY) holdings are associated with David A. Ricks?
Indirect holdings include 6,685 shares via the David A. Ricks 2025 GRAT, 54,117 shares via the 2022 GRAT, 300 shares via a trust, 68,656 shares via the David A. Ricks SLAT, and 7,311.26 shares through a 401(k) plan, all reported with a beneficial ownership disclaimer.
AI-generated analysis. How Rhea-AI works. Not financial advice.
